Inotiv (NOTV)
(Delayed Data from NSDQ)
$1.56 USD
+0.04 (2.63%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $1.55 -0.01 (-0.64%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.56 USD
+0.04 (2.63%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $1.55 -0.01 (-0.64%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth B Momentum C VGM
Zacks News
Here Is Why Bargain Hunters Would Love Fast-paced Mover Inotiv, Inc. (NOTV)
by Zacks Equity Research
Inotiv, Inc. (NOTV) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Wall Street Analysts Predict a 168.98% Upside in Inotiv, Inc. (NOTV): Here's What You Should Know
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 169% in Inotiv, Inc. (NOTV). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Inotiv, Inc. (NOTV) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Inotiv, Inc. (NOTV) delivered earnings and revenue surprises of -112.50% and 13.98%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Matinas Biopharma Holdings, Inc. (MTNB) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Matinas Biopharma Holdings, Inc. (MTNB) delivered earnings and revenue surprises of 0% and 265.33%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
4D Molecular Therapeutics, Inc. (FDMT) Surges 5.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
4D Molecular Therapeutics, Inc. (FDMT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of 13% and 0.30%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for Inotiv (NOTV) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Inotiv (NOTV) stock based on the movements in the options market lately.
Inotiv, Inc. (NOTV) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
Inotiv, Inc. (NOTV) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Bears are Losing Control Over Inotiv, Inc. (NOTV), Here's Why It's a 'Buy' Now
by Zacks Equity Research
Inotiv, Inc. (NOTV) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
The Zacks Analyst Blog Highlights: Inotiv, Sterling Construction Company, Level One Bancorp, Clearfield and Bluegreen Vacations
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Inotiv, Sterling Construction Company, Level One Bancorp, Clearfield and Bluegreen Vacations
Top 5 High-Flying Small-Cap Stocks to Tap Wall Street Rally
by Nalak Das
We have narrowed down our search to five small business operators that have popped more than 20% in the past month. These are NOTV, STRL, LEVL, CLFD and BVH.